175 related articles for article (PubMed ID: 29075878)
1. Treatment for Localized T1a Clear Cell Renal Cell Carcinoma: Survival Benefit for Cryosurgery and Thermal Ablation Compared to Deferred Therapy.
Uhlig A; Hahn O; Strauss A; Lotz J; Trojan L; Müller-Wille R; Uhlig J
Cardiovasc Intervent Radiol; 2018 Feb; 41(2):277-283. PubMed ID: 29075878
[TBL] [Abstract][Full Text] [Related]
2. Impact of Tumor Size on Cancer-Specific Mortality Rate After Local Tumor Ablation in T1a Renal-Cell Carcinoma.
Palumbo C; Cyr SJ; Mazzone E; Mistretta FA; Knipper S; Pecoraro A; Tian Z; Shariat SF; Saad F; Simeone C; Briganti A; Kapoor A; Antonelli A; Karakiewicz PI
J Endourol; 2019 Jul; 33(7):606-613. PubMed ID: 30990074
[No Abstract] [Full Text] [Related]
3. Stereotactic Body Radiotherapy for Stage I Renal Cell Carcinoma: National Treatment Trends and Outcomes Compared to Partial Nephrectomy and Thermal Ablation.
Uhlig A; Uhlig J; Trojan L; Kim HS
J Vasc Interv Radiol; 2020 Apr; 31(4):564-571. PubMed ID: 32127324
[TBL] [Abstract][Full Text] [Related]
4. Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis.
Choueiri TK; Schutz FA; Hevelone ND; Nguyen PL; Lipsitz SR; Williams SB; Silverman SG; Hu JC
Urology; 2011 Jul; 78(1):93-8. PubMed ID: 21550636
[TBL] [Abstract][Full Text] [Related]
5. A Comparison of Cryoablation with Heat-Based Thermal Ablation for Treatment of Clinical T1a Renal Cell Carcinoma: A National Cancer Database Study.
Wu J; Chang J; Bai HX; Su C; Zhang PJ; Karakousis G; Reddy S; Hunt S; Soulen MC; Stavropoulos SW; Zhang Z
J Vasc Interv Radiol; 2019 Jul; 30(7):1027-1033.e3. PubMed ID: 31176590
[TBL] [Abstract][Full Text] [Related]
6. Thermal ablation in renal cell carcinoma management: a comprehensive review.
Wagstaff P; Ingels A; Zondervan P; de la Rosette JJ; Laguna MP
Curr Opin Urol; 2014 Sep; 24(5):474-82. PubMed ID: 25051022
[TBL] [Abstract][Full Text] [Related]
7. Ablation versus Resection for Stage 1A Renal Cell Carcinoma: National Variation in Clinical Management and Selected Outcomes.
Uhlig J; Kokabi N; Xing M; Kim HS
Radiology; 2018 Sep; 288(3):889-897. PubMed ID: 29969077
[TBL] [Abstract][Full Text] [Related]
8. Population-based comparative effectiveness of nephron-sparing surgery vs ablation for small renal masses.
Whitson JM; Harris CR; Meng MV
BJU Int; 2012 Nov; 110(10):1438-43; discussion 1443. PubMed ID: 22639860
[TBL] [Abstract][Full Text] [Related]
9. Surgical salvage of renal cell carcinoma recurrence after thermal ablative therapy.
Nguyen CT; Lane BR; Kaouk JH; Hegarty N; Gill IS; Novick AC; Campbell SC
J Urol; 2008 Jul; 180(1):104-9; discussion 109. PubMed ID: 18485401
[TBL] [Abstract][Full Text] [Related]
10. Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies.
El Dib R; Touma NJ; Kapoor A
BJU Int; 2012 Aug; 110(4):510-6. PubMed ID: 22304329
[TBL] [Abstract][Full Text] [Related]
11. Surgical Salvage of Thermal Ablation Failures for Renal Cell Carcinoma.
Jiménez JA; Zhang Z; Zhao J; Abouassaly R; Fergany A; Gong M; Kaouk J; Krishnamurthi V; Stein R; Stephenson A; Campbell SC
J Urol; 2016 Mar; 195(3):594-600. PubMed ID: 26417642
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation versus cryoablation for T1b renal cell carcinoma: a multi-center study.
Hasegawa T; Yamanaka T; Gobara H; Miyazaki M; Takaki H; Sato Y; Inaba Y; Yamakado K
Jpn J Radiol; 2018 Sep; 36(9):551-558. PubMed ID: 29968201
[TBL] [Abstract][Full Text] [Related]
13. Partial Nephrectomy versus Thermal Ablation for Clinical Stage T1 Renal Masses: Systematic Review and Meta-Analysis of More than 3,900 Patients.
Rivero JR; De La Cerda J; Wang H; Liss MA; Farrell AM; Rodriguez R; Suri R; Kaushik D
J Vasc Interv Radiol; 2018 Jan; 29(1):18-29. PubMed ID: 29102464
[TBL] [Abstract][Full Text] [Related]
14. Cryoablation vs. radiofrequency ablation for small renal masses.
Pirasteh A; Snyder L; Boncher N; Passalacqua M; Rosenblum D; Prologo JD
Acad Radiol; 2011 Jan; 18(1):97-100. PubMed ID: 20880723
[TBL] [Abstract][Full Text] [Related]
15. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
Forauer AR; Dewey BJ; Seigne JD
Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
[TBL] [Abstract][Full Text] [Related]
16. SEER study of ablation versus partial nephrectomy in cT1A renal cell carcinoma.
Zhou M; Mills A; Noda C; Ramaswamy R; Akinwande O
Future Oncol; 2018 Jul; 14(17):1711-1719. PubMed ID: 29939095
[TBL] [Abstract][Full Text] [Related]
17. Tumor Growth Kinetics and Oncologic Outcomes of Patients Undergoing Active Surveillance for Residual Renal Tumor following Percutaneous Thermal Ablation.
Chen JX; Maass D; Guzzo TJ; Bruce Malkowicz S; Wein AJ; Soulen MC; Clark TWI; Nadolski GJ; William Stavropoulos S
J Vasc Interv Radiol; 2016 Sep; 27(9):1397-1406. PubMed ID: 27234485
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous Thermal Ablation for Treatment of T1a Renal Cell Carcinomas.
Shakeri S; Raman SS
Radiol Clin North Am; 2020 Sep; 58(5):981-993. PubMed ID: 32792128
[TBL] [Abstract][Full Text] [Related]
19. Minimally invasive surgery using ablative modalities for the localized renal mass.
Kimura M; Baba S; Polascik TJ
Int J Urol; 2010 Mar; 17(3):215-27. PubMed ID: 20070411
[TBL] [Abstract][Full Text] [Related]
20. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
